[Secondary glaucoma, pathogenesis and clinic (author's transl)].
D000086:Acetazolamide / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001082:Aqueous Humor / Q000378:metabolism; D005123:Eye / Q000098:blood supply; D005128:Eye Diseases / Q000150:complications; D005131:Eye Injuries / Q000150:complications; D005901:Glaucoma / Q000209:etiology / Q000601:surgery; D005990:Glycerol / Q000627:therapeutic use; D006801:Humans; D007036:Hypothermia, Induced / Q000627:therapeutic use; D007429:Intraocular Pressure; D008353:Mannitol / Q000627:therapeutic use; D009184:Mydriatics / Q000627:therapeutic use; D009883:Ophthalmic Solutions; D010862:Pilocarpine / Q000627:therapeutic use; D014605:Uveitis / Q000150:complications; D014652:Vascular Diseases / Q000150:complications
D000893:Anti-Inflammatory Agents; D009184:Mydriatics; D009883:Ophthalmic Solutions; D010862:Pilocarpine; D008353:Mannitol; D000086:Acetazolamide; D005990:Glycerol
Sekundärglaukome, Pathogenese und Klinik